Why the study?
Interaction between LVADs and S-ICDs is a matter of concern, as obtaining signals via subcutaneous vectors poses challenges to adequate performance after LVAD implantation.
Does the concomitant use of an LVAD interfere with the sensing and performance of an S-ICD?
Does the concomitant use of an LVAD interfere with the sensing and performance of an S-ICD?
Concomitant use of S-ICD and LVAD can lead to significant sensing disturbances and electromagnetic interference, potentially rendering the S-ICD ineffective.
Answers are grounded in this paper and cite their sources.
Concomitant LVAD may impair S-ICD sensing; case reports leave open optimal device selection strategies.
BACKGROUND: Left ventricular assist devices (LVAD) are increasingly used in patients with advanced heart failure, many of whom have been or will be implanted with an implantable cardioverter defibrillator (ICD). Interaction between both devices is a matter of concern. Subcutaneous ICD (S-ICD) obtains its signals through subcutaneous vectors, which poses special challenges with regards to adequate performance following LVAD implantation. CASE SUMMARY: We describe the case of a 24-year-old man implanted with an S-ICD because of idiopathic dilated cardiomyopathy, severe biventricular dysfunction, and self-limiting sustained ventricular tachycardias. After the implantation of a HeartMate 3™ (Left Ventricular Assist System, Abbott) several months later, the S-ICD became useless because of inappropriate sensing due to electromagnetic interference and attenuation of QRS voltage. DISCUSSION: We reviewed the reported cases in PubMed about the concomitant use of S-ICD and LVAD. Seven case reports about the performance of S-ICD in patients with an LVAD were identified, with discordant results. From these articles, we analyse the potential causes for these differing results. Pump location and operating rates in LVAD, as well as changes in the subcutaneous-electrocardiogram detected by the S-ICD after LVAD implantation are related to sensing disturbances when used in the same patient.
No takes yet. Share an insight, caveat, or question.
López‐Gil et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: